This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May;11(5):242.

doi: 10.1038/nrclinonc.2014.59. Epub 2014 Apr 1.

Gynaecological cancer: AURELIA--ovarian combination

PMID: 24687034
DOI: 10.1038/nrclinonc.2014.59

Comment

Gynaecological cancer: AURELIA--ovarian combination

Alessia Errico. Nat Rev Clin Oncol. 2014 May.

. 2014 May;11(5):242.

doi: 10.1038/nrclinonc.2014.59. Epub 2014 Apr 1.

Author

PMID: 24687034
DOI: 10.1038/nrclinonc.2014.59

No abstract available

PubMed Disclaimer

Comment on

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I. Pujade-Lauraine E, et al. J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24637997 Clinical Trial.

References

1. J Clin Oncol. 2014 May 1;32(13):1302-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information